Ubtech Robotics Ties Up With Mercedes-Benz Dealer to Sell Humanoids as Pre-Orders Exceed 11,000 Units

Ubtech Robotics partners with Boshi Group to sell U1 series humanoids in Beijing-Tianjin-Hebei, targeting high-net-worth clients through luxury car dealerships.

Ubtech Robotics has secured a distribution channel that puts its humanoid robots directly in front of some of China's wealthiest consumers. The Boshi Group, a strategic partner of Mercedes-Benz in China, signed an agreement on July 15 to become the first authorized reseller of Ubtech's UWORLD U1 series in the Beijing-Tianjin-Hebei region. The robots will be sold through Boshi's 4S dealerships, which include Mercedes-Benz and Hyundai locations, and will also be showcased in the group's "Mechanical Eden" experience space under a rental model aimed at high-net-worth clients.

The deal comes just days after Ubtech's global launch event in Shenzhen, where the company unveiled the U1 series as what it calls the world's first mass-produced, over-realistic full-size humanoid. Priced between 119,800 yuan (roughly $16,500) and 990,000 yuan (about $146,000), the lineup spans bionic models with eye cameras, chest sensors, and microphones, as well as companion robots for commercial use. Ubtech reported more than 11,000 pre-orders shortly after the event and displayed over 50 over-realistic models. The Walker C1, a commercial humanoid, also drew attention with a ballet performance at the Chain Expo 2026, where Ubtech served as the exclusive robot partner.

Production capacity remains a key variable. Ubtech has outlined plans to produce 20,000 units across its humanoid lineup in 2026, with roughly 15,000 of those already allocated to bionic models. Separately, the company is working with Siemens Digital Industries Software to reach an annual capacity of 10,000 units for its humanoid series. Deliveries of the new robots are set to begin in September.

On the financial front, the picture is one of narrowing losses but still significant red ink. The company posted a loss of 790 million yuan last year, down from 1.16 billion yuan in 2024, while continuing losses were most recently pegged at 703.191 million yuan. Revenue jumped 53% to 2 billion yuan from 1.31 billion yuan, signaling accelerating operational growth. Yet valuation remains a sticking point. Simply Wall St puts Ubtech's price-to-sales ratio at 18.2 — far above the industry average of 1.1 and even the machinery peer group's 10.8. The research firm estimates a fair P/S multiple of 7.4, implying significant downside from current levels. Adding to the risk, the vast majority of Ubtech's revenue is generated in mainland China, exposing the company to regulatory shifts or a domestic slowdown.

Investors have not been forgiving. The stock, listed in Frankfurt, closed at €9.70 on Wednesday — a modest 2.26% gain for the day — but that masked deeper pain. Over the past month, the shares have fallen 22.55%, and since the start of 2026 they are down 33.10%. The 52-week high of €17.00, reached in mid-January, is now 43% away, while the 52-week low of €8.91 was set as recently as July 13. The New York-listed Class H shares closed at $11.18 on July 14, up 6.99% for the day, though an analyst price target of 153.06 Hong Kong dollars suggests room for optimism among some observers. The company's market capitalization stands at roughly €4.76 billion.

Technical indicators offer little comfort. The stock is trading 17.08% below its 50-day moving average of €11.70 and 8.85% above its recent low. The relative strength index of 40.8 points to neutral territory, while the annualized 30-day volatility of 85.10% underscores just how sharply the shares can swing. A further data point from the secondary listing shows the 100-day moving average at €11.79, well above current prices.

The addition to the HKEX Tech 100 Index on July 13 provides a measure of institutional validation, but it does little to resolve the fundamental tension between Ubtech's operational momentum and its stretched valuation. With the U1 deliveries slated to start in September, the coming months will test whether the flood of pre-orders translates into actual revenue — and whether the stock can find a floor.